Aktiesnakken — August 2010
-
ret snæver periode: http://www.proinvestor.com/finansnyhed/10260590
-
2 måneder - 1 milliard
-
007 - det burde virke
-
-
Del af Mayos vej imod NGAL accept: http://www.mayomedicallaboratories.com/mediax/articles/hottopics/2009-8b-renal-failure/2009-8b-renal-fail
-
List Fee
$222.40 -
for en NGAL test (-plade går jeg ud fra
) fra Mayo -
budsiden er helt væk....
-
mon Thea får ret i at det ikke betyder alverden for omsætningen?
-
GES nyt om lovgivningen
-
nej Leeloo
-
der står ikke noget som vi ikke ved allerede faktisk
-
Nyheden om Mayo har inte med patentrettigheder at gøre
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind